- Home
- RVMD vs UMC Comparison
RVMD vs UMC Comparison
Compare RVMD & UMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | UMC |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | Taiwan |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 29.3B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | RVMD | UMC |
|---|---|---|
| Price | $161.65 | $24.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 19 | 0 |
| Target Price | ★ $140.84 | N/A |
| AVG Volume (30 Days) | 2.5M | ★ 16.0M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.92% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.22 |
| Revenue Next Year | $533.02 | $10.15 |
| P/E Ratio | ★ N/A | $18.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.00 | $6.56 |
| 52 Week High | $166.50 | $24.17 |
Technical Indicators
Market Signals| Indicator | RVMD | UMC |
|---|---|---|
| Relative Strength Index (RSI) | 61.78 | 68.58 |
| Support Level | $141.22 | $7.56 |
| Resistance Level | $166.50 | N/A |
| Average True Range (ATR) | 6.70 | 1.04 |
| MACD | 0.20 | -0.04 |
| Stochastic Oscillator | 85.99 | 98.45 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About UMC United Microelectronics Corporation (NEW)
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 5% market share in 2024 after TSMC and SMIC. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the US, and South Korea. UMC features a diverse customer base that includes Texas Instruments, MediaTek, Intel, Broadcom, Novatek, and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 19,000 people as of February 2025.